市場調査レポート

医療関連感染(HAI)管理の世界市場:消毒、滅菌、治療、検査

Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)

発行 Kalorama Information 商品コード 304515
出版日 ページ情報 英文 229 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
医療関連感染(HAI)管理の世界市場:消毒、滅菌、治療、検査 Hospital-Acquired Infection (HAI) Control Market (Disinfection, Sterilization, Treatment, Testing)
出版日: 2016年01月25日 ページ情報: 英文 229 Pages
概要

医療施設内での感染症管理とは、たいていの場合は外部から侵入してくる感染症に対して患者・職員を防御することを指します。他方、医療行為の途中で感染・発症してしまうような感染症 - 医療関連感染(HAI)または院内感染と呼ばれます - に対する懸念・関心が高まっています。HAIは術後創部から発生したり、疾患とは無関係の合併症として発生する場合があります。

当レポートでは、全世界および米国における医療関連感染(HAI)- 院内感染やその他の治療・医療行為関連の感染症 - の管理市場について調査し、主な感染症の予防方法や検査手法、治療手段の概要と動向、地域別市場分析、今後の市場参入機会、主要企業企業のプロファイルといった情報を取りまとめてお届けいたします。

エグゼクティブサマリー

イントロダクションと業界動向

  • 概要
  • 病原体の概要
  • 世界の人口統計
  • 病院による感染リスク評価
  • 経済的動向
  • 院内感染の低減に向けた政策
  • 医薬品メーカーとマーケターの動向

感染予防

  • 概要
    • 伝染方法
    • ハイリスク施設または部門
    • 技術概要
    • 滅菌と消毒
    • 設備とソリューション
      • 蒸気滅菌
      • 科学的滅菌
      • 滅菌剤
      • 中度の消毒
      • 放射線滅菌
      • 滅菌と消毒の検証システム
  • 市場概要
    • 地域別市場
    • 競合分析

感染検査

  • 概要
    • 薬剤耐性/感受性検査
    • 遺伝子型決定法
  • 特に深刻な医療感染検査
    • アシネトバクター・バウマニ
    • クロストリジウム・ディフィシレ
    • 院内肺炎
    • 緑膿菌
    • 黄色ブドウ球菌
    • 結核
    • 尿路感染
    • バンコマイシン耐性腸球菌
    • 人工呼吸器関連肺炎
  • 新たな展開
  • 市場概要
  • 市場規模と予測
  • 競合分析

感染治療

  • 概要
    • 抗菌治療の原則
    • 感染生物
    • 抗生物質感受性検査
    • 感染部位
    • 宿主防御と臓器機能
    • 抗生物質の薬物動態
    • 治療のモニタリング
  • 抗菌製品の分類
  • 治療ガイドライン
  • 主要製品
  • 新たな展開
  • 市場概要
  • 市場規模と予測
  • 競合分析

医療関連感染管理の市場機会

  • 市場の検討事項
  • 市場概要
  • 地域別の市場:先進国・新興国市場の分析

企業プロファイル

  • イントロダクション
  • Advanced Sterilization Products
    • 企業の業績
  • Becton, Dickinson and Company
  • Belimed
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge Group
  • Merck & Co
  • Nordion
  • Pfizer
  • Roche
  • サクラ精機
  • Steris
  • Tso3

主要プロバイダーの一覧

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: KLI5854190

Infection control in health care facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of health care is known as a nosocomial, or hospital acquired, infection. The infection may occur in a postoperative wound or as a complication unrelated to the disease or condition.

This Kalorama Information report, Hospital-Acquired Infections takes a solid look at

    Hospital-Acquired Infection Statistics Device Sterilization Market Hospital Area Disinfection Market HAI Testing Market Treatment Market Market Segmentation by Healthcare Location: Hospital, Nursing Home, Other Market Segmentation by Geographic Location: US, EU, Asia, Other

There are several challenges facing the healthcare industry which contribute to the problem of healthcare-acquired infections. These are outlined below:

  • Increasing health expenditures have promoted the use of reusable medical equipment and supplies. This has inadvertently added increased risk over disposable products.
  • The aging population is increasing the need for improved HAI prevention measures. These are among the most vulnerable patients.
  • Increasing disease incidence and comorbid conditions generates a growing at-risk population for HAIs.
  • Compliance among medical staff in HAI prevention measures is still a concern, despite the growing awareness and education efforts.
  • Reducing HAIs to at or below the national average is acceptable. This may slow aggressiveness once this goal is realized.

Market analysis in this report considers primarily the epidemiological considerations and the size patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital and primary care environment in order to construct a picture of the infection prevention, testing and treatment needs.

ISSUES AND TRENDS AFFECTING MARKET

The area of hospital infections represents a difficult market landscape with several key trends affecting a product manufacturer's ability to successfully operate in the market, including:

  • Development of fast testing systems
  • Growing drug resistance
  • Attention to special population issues
  • Demographics and epidemiology
  • New government guidelines and requirements for preventing infection

Special considerations must be addressed while evaluating the potential market opportunities and restraints, including:

  • Nosocomial infections are a fact of life-while the incidence of any specific nosocomial infection may decline, it will be compensated for by the rise of a new infection or an increase in the incidence of another, existing, nosocomial infection.
  • The incidence of drug-resistant nosocomial infections is on the rise and can be expected to accelerate in the near future.
  • Multi-drug- or extensive-drug-resistance will further limit the effectiveness of existing therapeutics, and require improved detection of disease and treatment plans.
  • The hospital setting is badly in need of new, rapid testing procedures to define a pathogen's susceptibility to antibacterial treatment.
  • Other inpatient facilities, such as long-term care, are increasingly demanding products to reduce the risk of infection.
  • The hospital setting and the public health environment as a whole are in need of new antimicrobial therapeutic agents to combat infection, however the pipeline for these therapies is limited-calling for a need in prevention and detection.
  • Focus on alliances and partnerships to expand development programs.

LEADING COMPETITORS

The majority of competitive participation for hospital infection control and is in the United States and Europe. However, competition is steadily escalating in the United States and Europe, which is encouraging more participation in other areas such as Asia and Latin America. Companies included in this chapter are:

  • Advanced Sterilization Products
  • Becton Dickinson
  • Belimed AG
  • bioMerieux
  • Cantel
  • Cepheid
  • Getinge
  • Merck & Co.
  • Nordion
  • Pfizer
  • Roche
  • Sakura Seiki
  • Steris
  • TSO3

In looking at infections in the health environment, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for preventing, detecting and treating these infections. To some extent, we are limited by the activity of the industries associated with the activities mentioned above for these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

RESEARCH METHODOLOGY

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.

Table of Contents

EXECUTIVE SUMMARY

  • Overview
  • The Nosocomial Infection
  • Market Scope
  • Research Methodology
  • Industry Challenges
  • Total Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Leading Competitors

INTRODUCTION AND INDUSTRY TRENDS

  • Overview
  • Introduction to Pathogens
  • Classification of Antibacterial Organisms
  • Common Hospital (nosocomial) Infections
  • Description of Infections
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Gastroenteritis
  • Hospital-Acquired Pneumonia (HAP)
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus/Methicillin-Resistant Staphylococcus Aureus
  • Stenotrophomonas Maltophilia
  • Tuberculosis
  • Urinary Tract Infections
  • Vancomycin-Resistant Enterococcus
  • Ventilator-Associated Pneumonia (VAP)
  • Patient Risk Factors
  • General Populations at Risk for Infection
  • World Demographics
  • Assessing the Problem: Nosocomial Infection Statistics
  • Infection Risk Assessments by Hospital Department
  • Burn Units
  • Intensive Care Units
  • Emergency Departments
  • Hospital Length of Stay
  • Increased Hospital Length of Stay for HAIs
  • Extended Stay Environments
  • International Trends in Nursing Facilities
  • Economic Trends
  • Comparison between Healthcare Spending and Real Health Outcomes
  • U.S. Government's National Plan to Prevent Healthcare Associated Infections (HAIs)43
  • Steering Committee
  • Affordable Care Act (ACA) Funding
  • Government Funding for HAI Prevention Infrastructure Activities
  • The Department of Health and Human Services: 2016 Budget Highlights
  • National Healthcare Safety Network
  • Hospital infection Surveillance Process
  • Screening Hospitalized Patients
  • Pharmaceutical Manufacturer and Marketer Trends
  • Trends in Partnerships and Alliances
  • Developers Trends

INFECTION PREVENTION

  • Overview
  • Methods of Transmission
  • Airborne
  • Contact
  • Droplet
  • Vehicle
  • High-Risk Facilities or Departments
  • Technology Overview
  • Potential Use of Copper for Reducing Infections
  • Wide Area Disinfection Methods
  • Software for Infection Detection and Control
  • Antiseptic-Coated Catheters
  • UV-C Reflective Coatings
  • Specialized Disinfection/Sterilization Systems
  • Sterilization vs. Disinfection
  • Sterilization
  • Disinfection
  • Equipment and Solutions
  • Heat/Steam Sterilization
  • Product Examples
  • Chemical Sterilization
  • Sterilants
  • Product Examples
  • Mid-Level Disinfectants
  • Suppliers
  • Radiation Sterilization
  • Product Examples
  • Sterilization and Disinfection Verification Systems
  • Market Overview
  • Hospital infection Prevention Market by Geographical Region
  • Competitive Analysis

INFECTION TESTING

  • Overview
  • Drug-Resistance/Susceptibility Testing
  • Genotypic Methods
  • DNA Sequencing
  • Solid-phase Hybridization Techniques
  • Microarrays
  • Real-time Polymerase Chain Reaction Techniques
  • Phenotypic Methods
  • Phage-based Assays
  • Colorimetric Methods
  • The Nitrate Reductase Assay
  • Specific Serious Hospital infection Testing
  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Product Examples
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Vancomycin-Intermediate/Resistant Staphylococcus Aureus (VISA/VRSA)
  • Product Examples
  • Tuberculosis
  • Product Examples
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Ventilator-Associated Pneumonia
  • New Developments
  • Market Overview
  • Total Market Size and Forecast
  • Hospital infection Testing Market by Geographical Region
  • Competitive Analysis

INFECTION TREATMENT

  • Overview
  • Principles of Anti-bacterial Therapy
  • Infecting Organism
  • Antibiotic Sensitivity Testing
  • Site of Infection
  • Host Defenses and Organ Function
  • Antibiotic Pharmacokinetics
  • Monitoring Therapy
  • Classifications of Antibacterial Products
  • Carbapenems
  • Cephalosporins
  • Macrolides
  • Penicillins
  • Quinolones
  • Sulfonamides
  • Tetracyclines
  • Infections and Drug Resistance
  • Easing Approvals of Antibiotics
  • Causes of Drug Resistance
  • Antibiotic Abuse
  • Antibiotic Use in Agriculture
  • Drug Resistance in Select Populations
  • Children
  • The Elderly
  • Compromised Individuals
  • Measures for Reducing Resistance
  • Testing for the Selection of Anti-bacterial Therapy
  • Monitoring Therapy
  • Treatment Guidelines
  • Clostridium Difficile
  • Gastroenteritis
  • Hospital-Acquired Pneumonia
  • Ventilator-associated Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Stenotrophomonas maltophilia
  • Tuberculosis
  • Urinary Tract Infections
  • Leading Products
  • New Developments
  • Development Incentives
  • Total Market Size and Forecast
  • Hospital infection Treatment Market by Geographical Region
  • Competitive Analysis

MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL

  • Market Considerations
  • Market Overview
  • Healthcare-Acquired Infection Distribution by Setting
  • The Global Market for Hospital infection Control Estimated Market Share by Facility Setting, 2015
  • The Global Market for Hospital infection Control Estimated Market Share by Hospital Department,2015
  • Hospital infection Control Market by Geographical Region
  • Developed and Emerging Market Analysis

COMPANY PROFILES

  • Introduction
  • Advanced Sterilization Products
  • Company Performance
  • Becton, Dickinson and Company
  • Company Performance
  • Belimed
  • Company Performance
  • bioMerieux
  • Company Performance
  • Cantel
  • Company Performance
  • Cepheid
  • Company Performance
  • Getinge Group
  • Company Performance
  • Merck & Co
  • Company Performance
  • Nordion
  • Company Performance
  • Pfizer
  • Company Performance
  • Roche
  • Company Performance
  • Sakura Seiki
  • Steris
  • Company Performance
  • Tso3
  • Company Performance

LIST OF MAJOR PROVIDERS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

  • Table 1-1: Frequency of the Most Common Nosocomial Infections
  • Table 1-2: Growth Drivers and Inhibitors
  • Table 1-3: The Global Market for Hospital infection Control 2010-2020
  • Figure 1-1: The Global Market for Hospital infection Control 2010-2020

INTRODUCTION AND INDUSTRY TRENDS

  • Table 2-1: Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region(US, EU, Asia, ROW)
  • Figure 2-1: Global Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region(US, EU, Asia, ROW)
  • Table 2-2: Global Population Change, 2005 - 2050
  • Figure 2-2: Global Population Change, 2005-2050
  • Table 2-3: World Population by Selected Geographical Region(US, EU, Asia, ROW), 2010 - 205030
  • Figure 2-3: World Population by Selected Geographical Region(US, EU, Asia, ROW), 2010-205030
  • Figure 2-4: U.S. Hospital Admissions and Percent of Hospital-acquired Infections (HAIs)by Type - (MRSA, C.diff, Other)
  • Figure 2-5: European Union Hospital Admissions and Percent of Hospital-acquired Infections(HAIs) by Type (Bloodstream, Upper&Lower RTI, MRSA, Other)
  • Figure 2-6: Average International Length of Stay (LOS), by Country 2015 Estimates
  • Figure 2-7: Number of Nursing Homes (United States), 2000-2012
  • Figure 2-8: Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2014
  • Table 2-4: U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2015
  • Table 2-4 (continued): U.S. States ACA HAI Prevention Infrastructure Funding Awards, 2013-2015
  • Table 2-5: U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011, 2012 and 2013
  • Figure 2-9: U.S. Hospital Acquired Infection Standardized Infection Ratio (SIR) 2010, 2011, 2012 and 2013

INFECTION PREVENTION

  • Table 3-1: Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants
  • Table 3-1 (continued): Summary of Advantages and Disadvantages of Chemical Agents Used as Chemical Sterilants1 or as High-Level Disinfectants
  • Table 3-2: Comparison of the Characteristics of Selected Chemicals Used as High-Level Disinfectants or Chemical Sterilants
  • Table 3-3: Comparison of the Characteristics of Selected Hospital Disinfectants for General Disinfection of Environmental Surfaces
  • Table 3-4: New Developments, Hospital infection Prevention
  • Table 3-5: The Global Market for Hospital infection Prevention Equipment and Consumables 2010-2020
  • Figure 3-1: The Global Market for Hospital infection Prevention Equipment and Consumables 2010-2020
  • Figure 3-2: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Value by Use, (Medical Device/Instrument Sterilization, Wide-Area/Room Sterilization, Medical-grade Disinfection Solutions, Other Products)2010-2020
  • Figure 3-3: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Share by Department/Use, 2015
  • Figure 3-4: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Value by Technology, 2010-2020
  • Figure 3-6: The Global Market for Hospital infection Prevention Equipment and Consumables Estimated Market Share by Technology, 2015
  • Table 3-6: The Global Market for Hospital infection Prevention Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 3-7: The Global Market for Hospital infection Prevention Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 3-8: The World Market for Hospital infection Prevention Estimated Market Share by Region, 2015
  • Table 3-7: The Global Market for Hospital infection Prevention Leading Suppliers' Shares Estimates for 2015
  • Figure 3-9: The Global Market for Hospital infection Prevention Leading Suppliers' Shares Estimates for 2015

INFECTION TESTING

  • Table 4-1: Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Table 4-1 (continued): Significant Approvals for Detecting Serious Hospital infections
  • Figure 4-1: HAI Test Approvals* in the U.S. by Year and Type, 2000-2015
  • Table 4-2: New Developments, Hospital infection Testing
  • Table 4-3: The Global Market for Hospital infection Testing/Diagnostics 2010-2020
  • Figure 4-2: The Global Market for Hospital infection Testing/Diagnostics 2010-2020
  • Figure 4-3: The Global Market for Hospital infection Testing/Diagnostics Estimated Market Share by Test Indication, 2015
  • Table 4-4: The Global Market for Hospital infection Testing/Diagnostics Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 4-4: The Global Market for Hospital infection Testing/Diagnostics Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 4-5: The Global Market for Hospital infection Testing/Diagnostics Estimated Market Share by Region, 2015
  • Table 4-5: The Global Market for Hospital infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2015
  • Figure 4-6: The Global Market for Hospital infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2015

INFECTION TREATMENT

  • Table 5-1: Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-1 (continued): Treatment Options for Bacterial Infections (Type, Brand, and Manufacturer)
  • Table 5-2: Antibiotics with Difficult Penetration
  • Table 5-2 (continued): Antibiotics with Difficult Penetration
  • Table 5-3: Annual Sales of Select Antibacterial Products 2014
  • Table 5-4: New Developments, Hospital infection Treatments, as of December 2015
  • Table 5-4 (continued): New Developments, Hospital infection Treatments
  • Table 5-4 (continued): New Developments, Hospital infection Treatments
  • Table 5-5: The Global Market for Hospital infection Treatment 2010-2020
  • Figure 5-1: The Global Market for Hospital infection Treatment 2010-2020
  • Table 5-6: The Global Market for Hospital infection Treatment Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 5-2: The Global Market for Hospital infection Treatment Estimated Product Sales by Primary Geographic Region 2010-2020
  • Figure 5-3: The Global Market for Hospital infection Treatment Estimated Market Share by Region, 2015
  • Table 5-7: The Global Market for Hospital infection Treatment Leading Suppliers' Shares Estimated Share for HAIs for 2015
  • Figure 5-4: The Global Market for Hospital infection Treatment Leading Suppliers' Shares Estimated Share for HAIs for 2015

MARKET OPPORTUNITIES FOR HOSPITAL INFECTION CONTROL

  • Table 6-1: The Global Market for Hospital infection Control 2010-2020
  • Figure 6-1: The Global Market for Hospital infection Control 2010-2020
  • Figure 6-2: The Global Market for Hospital infection Control Estimated Market Share by Segment, 2015
  • Figure 6-3: The Global Market for Hospital infection Control Estimated Market Share by Facility Setting, 2015
  • Figure 6-4: The Global Market for Hospital infection Control Estimated Market Share by Hospital Department, 2015
  • Table 6-2: The Global Market for Hospital infection Control Estimated Products Sales by Primary Geographic Region 2010-2020
  • Figure 6-5: The Global Market for Hospital infection Control Estimated Product Sales by Geographic Region 2010-2020
  • Figure 6-6: The Global Market for Hospital infection Control Estimated Market Share by Geographic Region, 2015
  • Table 6-3: Developed vs. Emerging Markets
  • Figure 6-7: The Global Market for Hospital infection Control Estimated Market Share by Region, 2015

COMPANY PROFILES

LIST OF MAJOR PROVIDERS

Back to Top